Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Regions Favor Large Insurers, Small PBMs

Executive Summary

The decision to create 34 separate regions for stand-alone drug plans under Medicare Part D is intended to encourage more sponsors to participate in the program, Centers for Medicare & Medicaid Services Administrator Mark McClellan said during a Dec. 6 press conference

You may also be interested in...



CMS Could Award Up To 250 Part B Rx Contracts Under Bidding Program

Medicare could award anywhere from five to 250 separate Part B drug vendor contracts under the competitive acquisition program depending on how the Centers for Medicare & Medicaid Services ends up defining bidding areas

CMS Could Award Up To 250 Part B Rx Contracts Under Bidding Program

Medicare could award anywhere from five to 250 separate Part B drug vendor contracts under the competitive acquisition program depending on how the Centers for Medicare & Medicaid Services ends up defining bidding areas

Medicare Rx Will Be Truly Competitive, CMS Says: 2-5 Plans Per Region

The Centers for Medicare & Medicaid Services expects there will be two to five prescription drug plans in each region when the drug benefit begins in 2006, Deputy Administrator Leslie Norwalk said Jan. 10

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045102

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel